Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for Epidermolysis Bullosa Simplex
NCT02470689Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jun 2015
- Primary completion
- Dec 2017
01
Overview
A Phase 2 trial of AC-203 in epidermolysis bullosa simplex (EBS), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
AC-203
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on NCT02470689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470689.